BIA MEP Brexit briefing, June 2019

The Cell and Gene Therapy Catapult is launching a Technology Advisory Board to accelerate the UK’s leadership in advanced therapies.

In this blog, Richard Turner, Senior Managing Director at FTI Consulting, discusses how licence and collaboration agreements in life sciences can create significant tax consequences.

It’s been an energising week across the UK life sciences landscape, marked by major investment, important conversations and new opportunities for our community.

Each month, our Policy and Public Affairs team will showcase how we are championing members’ voices in Government and Parliament.

In this blog, Jane Wall, Managing Director of the BioIndustry Association (BIA), reflects on a roundtable with the Milken Institute and Jill Biden.

FUJIFILM Biotechnologies celebrated the grand opening of its expanded site in Teesside, UK, today.